- Home
- Behind the science magazine
- Combining genetics and tech to double success rates
- Getting ahead of infectious diseases with advanced technology
- Could tiny bubbles released from bacteria cells pave the way for new vaccine technology
- How adjuvants boost our immune response
- Following the science of oxygen to discover solutions for anaemia
- AI and ML power better predictions for patient impact
- Fresh insights could finally help us tackle RSV
- How we're getting ahead of an incurable blood cancer
- Computational Biology: setting the stage for future wins and new medicines
- Targeting treatable traits in asthma and other respiratory conditions
- Why we’re introducing Shingles Awareness Week
- Tech for T-cells single cell RNA seq measures shifts in immune cells to pinpoint causes of disease
- What if remission were the target of lupus care?
- How vaccine science can help tackle antimicrobial resistance
- 1.4 million reasons to get ahead of gynaecologic cancers
- How the next generation of immuno-oncology could help us get ahead of cancer
- The 40 year fight against HIV
- Synthetic Lethality: accelerating precision cancer treatments
- Digital twin: using advanced technology to accelerate vaccine development
- Tackling tomorrow’s health challenges today
- Unlocking the power of the immune system to get ahead of hepatitis B
- Time for a change: personalising asthma treatment
- Eosinophils could be holding the missing link between symptoms, diagnosis and treatment
- The logic of biologic medicines: advancing care for people with immune-mediated conditions
- Getting ahead of COPD exacerbations using new tech could save lives
- Using new science to get ahead of myelofibrosis - a rare blood cancer
- Antibiotic resistance: now’s the time to prevent the next pandemic
- Harnessing tumour DNA to detect cancer recurrence earlier
- The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact
- ‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development
- Age-related decline in immunity: why does it matter and what can be done about it?
- ‘I had never experienced anything like it’: the pain, risks, and first symptoms of shingles every adult should know
- How representation in clinical trials improves health outcomes for women
- Modern technologies are doubling the odds of scientists making life-changing medical discoveries
- Scientists gain ground in centuries-long malaria struggle – but more innovation is needed to stay ahead of evolving parasites
- ‘300 million people with chronic hepatitis B are waiting to re-start their lives. This is my story of hope.’
- New digital assessment tool could improve the lives of people living with HIV by helping healthcare professionals uncover hidden burdens
- Back to school immunity: vaccination catch-ups are needed to stop the escalation of preventable diseases in children
- Biopharma experts believe a ‘greater exchange of skills and technology’ will deliver the best results for patients
- Biomarker testing is helping doctors find precision treatments for patients that could dramatically improve health outcomes
- ‘AI has already transformed medical innovation. Let’s not let fears of technology stop us from realising its incredible potential’
- Millions of people living with chronic hepatitis B are unaware they have the virus. So why aren’t they getting diagnosed?
- ‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about
- A preventative patient-centred approach is key to transforming respiratory care and relieving struggling services
- ‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’
- In the face of climate change, vaccines play a crucial but underestimated role
- Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
- ‘It is both a strategic and a moral imperative’: Why closing the health equity gap is better for everyone
- ‘Local innovation is vital to our mission to ensure no child is left to suffer from a vaccine preventable disease’
- ‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage
- ‘Global health progress is vital for millions of lives, but it isn’t going fast enough. Here’s what we need to do to get things back on track’
- Advanced technology is increasing the chances of improving outcomes for cancer patients
- 'Scientists need rich and accessible data at scale to make the best possible impact for patients’
- ‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease
- ‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic?
- Remission could be possible for people with asthma, giving them a new outlook on life
- 6 in 10 of adults over 50 have never heard of RSV, despite some being among those most at risk of infection
- ‘My cough interferes with everything’: New research could help refractory chronic cough patients after decades of depression, pain, and sleep loss
- ‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’
- ‘We never think AMR is going to happen to us’: The human cost of antimicrobial resistance – and how to prevent it
- ‘Teenagers may feel invincible – but we’re at risk’: What you need to know about meningitis as post-COVID cases continue to rebound
- 'Prevention is the best medicine to stop disease before it starts'
- 78% of gynaecologic cancer patients experience challenges accessing the treatment they need, new survey shows
- ‘It was not something I was warned about’: Preventing permanent organ damage in patients with lupus
- ‘The whooping cough outbreak is a stark reminder of just how important lifelong vaccination is’
- Is it COVID-19, flu, or RSV? The symptoms to look out for – and how to tell the difference
- ‘Long-acting therapies are no longer the future of HIV treatment – they are the now’
- Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk
- ‘Cancer doesn’t have to be a deadly disease – it’s our goal to make it curable’
- ‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics
- Vaccinations are not just for children: why adult immunisation is a health and economic necessity
- ‘We’re aiming to protect even more children’: Research starts on second-generation malaria vaccine to prevent most severe form of disease
- ‘How do we improve trust in prevention? The answer lies closer to home than you might think’
- ‘Finding the right treatment for my asthma and nasal polyps has transformed my life. I hope my experience can help others achieve the same’
- ‘I feel hopeless and frustrated’: Why patients living with incurable blood cancers need more treatment options
- ‘Digital biological twins and organoids might sound like sci-fi, but they’re real – and we’re using them to fight cancer’
- Company
- Locations
- Innovation
- Products
- Responsibility
- Investors
- Media
- Careers
- Accessibility
- Digital sustainability
- Terms of use
- Cookie policy